UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Renal function as a predictor of outcome in a broad spectrum of patients with heart failure

Circulation (New York, N.Y.), 2006-02, Vol.113 (5), p.671-678

2006

Volltextzugriff (PDF)

Predictors of mortality and morbidity in patients with chronic heart failure

European heart journal, 2006-01, Vol.27 (1), p.65-75

2006

Volltextzugriff (PDF)

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial

The Lancet (British edition), 2005-09, Vol.366 (9489), p.895-906

2005

Volltextzugriff (PDF)

Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)

The Lancet (British edition), 2005-09, Vol.366 (9489), p.907-913

2005

Volltextzugriff (PDF)

Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure : Results of the candesartan in heart failure: Assessment of reduction in mortality and morbidity (CHARM) program

Circulation (New York, N.Y.), 2007-06, Vol.115 (24), p.3111-3120

2007

Volltextzugriff (PDF)

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

The Lancet (British edition), 2003-04, Vol.361 (9364), p.1149-1158

2003

Volltextzugriff (PDF)

Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure : Results of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program

Circulation (New York, N.Y.), 2006-02, Vol.113 (7), p.986-994

2006

Volltextzugriff (PDF)

Physicians’ and nurses’ perceptions of patient safety risks in the emergency department

International emergency nursing, 2017-07, Vol.33, p.14-19

2017

Volltextzugriff (PDF)

Predictors of Development of Diabetes in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program

Diabetes care, 2009-05, Vol.32 (5), p.915-920

2009

Volltextzugriff (PDF)

Amino-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity C-Reactive Protein but Not Cystatin C Predict Cardiovascular Events in Male Patients with Peripheral Artery Disease Independently of Ambulatory Pulse Pressure

American journal of hypertension, 2014-03, Vol.27 (3), p.363-371

2014

Volltextzugriff (PDF)

Clinical Outcomes According to Baseline Blood Pressure in Patients With a Low Ejection Fraction in the CHARM (Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity) Program

Journal of the American College of Cardiology, 2008-12, Vol.52 (24), p.2000-2007

2008

Volltextzugriff (PDF)

Improvement of blood pressure control and physicians' management over time in patients with coronary artery disease

Blood pressure, 2016-10, Vol.25 (5), p.286-291

2016

Volltextzugriff (PDF)

Dyslipidemia is a strong predictor of myocardial infarction in subjects with chronic kidney disease

Annals of medicine (Helsinki), 2012-05, Vol.44 (3), p.262-270

2012

Volltextzugriff (PDF)

Prevalence and prognostic impact of bundle branch block in patients with heart failure: Evidence from the CHARM programme

European journal of heart failure, 2007-05, Vol.9 (5), p.510-517

2007

Volltextzugriff (PDF)

Retinopathy of Prematurity Is Associated with Increased Systolic Blood Pressure in Adults Who Were Born Preterm

Neonatology (Basel, Switzerland), 2017-01, Vol.112 (1), p.87-91

2017

Volltextzugriff (PDF)

Resource utilization and costs in the Candesartan in Heart failure : Assessment of Reduction in Mortality and morbidity (CHARM) programme

European heart journal, 2006-06, Vol.27 (12), p.1447-1458

2006

Volltextzugriff (PDF)

From hypertension to heart failure -- are there better primary prevention strategies?

Journal of the renin-angiotensin-aldosterone system, 2006-06, Vol.7 (2), p.64-73

2006

Volltextzugriff (PDF)

Change in blood pressure during hospitalisation for acute heart failure predicts mortality

Scandinavian cardiovascular journal : SCJ, 2010-12, Vol.44 (6), p.325-330

2010

Volltextzugriff (PDF)

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

European heart journal, 2013-07, Vol.34 (28), p.2159-2219

2013

Volltextzugriff (PDF)

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

European heart journal, 2013-10, Vol.34 (39), p.3035

2013

Volltextzugriff (PDF)

Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure

The New England journal of medicine, 2016-04, Vol.374 (16), p.1521-1532

2016

Volltextzugriff (PDF)

Amlodipine+Benazepril is Superior to Hydrochlorothiazide+Benazepril Irrespective of Baseline Pulse Pressure: Subanalysis of the ACCOMPLISH Trial

The journal of clinical hypertension (Greenwich, Conn.), 2015-02, Vol.17 (2), p.141-146

2015

Volltextzugriff (PDF)

Hypertension is a clinical problem ... even though we have tools to solve it

Läkartidningen, 2012-09, Vol.109 (36), p.1544-1548

Ostergren, Jan

2012

Volltextzugriff (PDF)

Myocardial ischaemia in patients with peripheral arterial disease

Clinical physiology and functional imaging, 2007-01, Vol.27 (1), p.30-35

2007

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Aktive Filter

ThemaRisk Factors

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(34)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Renal function as a predictor of outcome in a broad spectrum of patients with heart failure

Predictors of mortality and morbidity in patients with chronic heart failure

Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)

Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure : Results of the candesartan in heart failure: Assessment of reduction in mortality and morbidity (CHARM) program

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure : Results of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program

Physicians’ and nurses’ perceptions of patient safety risks in the emergency department

Predictors of Development of Diabetes in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program

Amino-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity C-Reactive Protein but Not Cystatin C Predict Cardiovascular Events in Male Patients with Peripheral Artery Disease Independently of Ambulatory Pulse Pressure

Clinical Outcomes According to Baseline Blood Pressure in Patients With a Low Ejection Fraction in the CHARM (Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity) Program

Improvement of blood pressure control and physicians' management over time in patients with coronary artery disease

Dyslipidemia is a strong predictor of myocardial infarction in subjects with chronic kidney disease

Prevalence and prognostic impact of bundle branch block in patients with heart failure: Evidence from the CHARM programme

Retinopathy of Prematurity Is Associated with Increased Systolic Blood Pressure in Adults Who Were Born Preterm

Resource utilization and costs in the Candesartan in Heart failure : Assessment of Reduction in Mortality and morbidity (CHARM) programme

From hypertension to heart failure -- are there better primary prevention strategies?

Change in blood pressure during hospitalisation for acute heart failure predicts mortality

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure

Amlodipine+Benazepril is Superior to Hydrochlorothiazide+Benazepril Irrespective of Baseline Pulse Pressure: Subanalysis of the ACCOMPLISH Trial

Hypertension is a clinical problem ... even though we have tools to solve it

Myocardial ischaemia in patients with peripheral arterial disease

Aktive Filter

Suchergebnisse filtern